Announcement of transactions with shares and linked securities in H. Lundbeck A/S made by executives and their closely associated persons and legal entities


H. Lundbeck A/S hereby reports transactions made by executives and
persons and legal entities closely associated to them with shares in
H. Lundbeck A/S and linked securities, cf. section 28a of the Danish
Securities Trading Act.

The list is based on reports received by H. Lundbeck A/S from the
company's executives today or yesterday.


+-------------------------------------------------------------------+
| Name:                           | Ulf Arne Wiinberg               |
|                                 |                                 |
|---------------------------------+---------------------------------|
| Job position of the executive:  | President and CEO from 1 June   |
|                                 | 2008                            |
|---------------------------------+---------------------------------|
| Relation to executive           |                                 |
| (associated person or legal     |                                 |
| entity):                        |                                 |
|---------------------------------+---------------------------------|
| ID code (ISIN code):            | DK 0010287234 / CUSIP 40422M107 |
|                                 |                                 |
|---------------------------------+---------------------------------|
| Description of the security:    | ADR                             |
|                                 |                                 |
|---------------------------------+---------------------------------|
| Nature of the transaction:      | Purchase of ADR                 |
|                                 |                                 |
|---------------------------------+---------------------------------|
| Date of trading:                | 27 May 2008                     |
|                                 |                                 |
|---------------------------------+---------------------------------|
| Market on which the trading was | Pink Sheets Level 1 /           |
| effected:                       | unsponsored program             |
|---------------------------------+---------------------------------|
| Number of traded securities:    |            2,000 | ADR          |
|                                 |                  |              |
|---------------------------------+------------------+--------------|
| Market price of securities      |          235,000 | DKK          |
| traded:                         |                  |              |
|                                 |                  |              |
+-------------------------------------------------------------------+




Persons/entities under an obligation to report
Persons or entities under an obligation to report are defined as
members of the Executive Management and the Supervisory Board of H.
Lundbeck A/S and persons/entities closely associated to them.

Closely associated persons/entities means inter alia:
*            spouse or cohabitant
*            children below the age of 18
*            legal entities in which the insider has a controlling
  influence

The content of this release will have no influence on the Lundbeck
Group's financial result for 2008.

Lundbeck contacts


Investors:                 Media:

Jacob Tolstrup             Jens Harder Højbjerg
Director                   Media Relations Manager
+45 36 43 30 79            +45 36 43 28 33

Palle Holm Olesen
Head of Investor Relations
+45 36 43 24 26


Stock Exchange Release No 347 - 30 May 2008

About Lundbeck
H. Lundbeck A/S is an international pharmaceutical company engaged in
the research and development, production, marketing and sale of
pharmaceuticals for the treatment of psychiatric and neurological
disorders. In 2007, the company's revenue was DKK 11 billion
(approximately EUR 1.6 billion or USD 2.0 billion). The number of
employees is approx. 5,300 globally. For more information, please
visit www.lundbeck.com.

Attachments

Release No 347 in pdf format